A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma
Conditions: Advanced Solid Tumor; Cutaneous T-cell Lymphoma (CTCL) Intervention: Drug: SIM1811-03 Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials